Show simple item record

dc.contributor.author Ζησιμόπουλος, Αθανάσιος Σ. el
dc.contributor.author Κυριατζής, Γ. el
dc.contributor.author Μπαμπάτσικου, Φωτούλα Π. el
dc.contributor.author Ψύλλας, Δημήτρης el
dc.contributor.author Καραθάνος, Ευάγγελος el
dc.date.accessioned 2015-04-24T08:55:06Z
dc.date.issued 2015-04-24
dc.identifier.uri http://hdl.handle.net/11400/8833
dc.rights Αναφορά Δημιουργού-Μη Εμπορική Χρήση-Όχι Παράγωγα Έργα 3.0 Ηνωμένες Πολιτείες *
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/3.0/us/ *
dc.source http://pharmakonpress.gr/ en
dc.source http://www.scopus.com en
dc.subject Pharmacokinetics
dc.subject Φαρμακοκινητική
dc.subject ιχνηθέτης
dc.subject Tracer
dc.title Technetium 99m, as a tracer in nuclear medicine procedures en
heal.type journalArticle
heal.classification Ιατρική
heal.classification Πυρηνική ιατρική
heal.classification Medicine
heal.classification Nuclear medicine
heal.classificationURI **N/A**-Ιατρική
heal.classificationURI **N/A**-Πυρηνική ιατρική
heal.classificationURI http://id.loc.gov/authorities/subjects/sh00006614
heal.classificationURI http://id.loc.gov/authorities/subjects/sh85093011
heal.keywordURI http://id.loc.gov/authorities/subjects/sh00006940
heal.contributorName Κουτής, Χαρίλαος el
heal.dateAvailable 10000-01-01
heal.language en
heal.access forever
heal.publicationDate 2009
heal.bibliographicCitation Zisimopoulos, A., Kyriatzis, G., Babatsikou, F., Psyllas, D., Karathanos, E., et. al. (2009). Technetium 99m, as a tracer in nuclear medicine procedures. "Review of Clinical Pharmacology and Pharmacokinetics International Edition". [online] 23(3): p.171-176. Available from: http://www.scopus.com [Accessed 21/04/2015] en
heal.abstract Technetium 99m is a metastable artificial radioisotope used as a radiotracer with advanced and plenty applications in Nuclear Medicine. It is the decay product (daughter element) of Mo-99 following beta decay with half life of 6.03 hours in its metastable state. It has properly physical and chemical characteristics and thus plays a lead role in radiopharmaceutical industry. Under appropriate conditions such as oxidation number, pH, hydrophilic characteristics can produce multiple stable complexes applicative to participate in almost any physical or metabolic pathways to identify a disease or pathological conditions. el
heal.journalName Review of Clinical Pharmacology and Pharmacokinetics International Edition el
heal.journalType peer-reviewed
heal.fullTextAvailability false


Files in this item

Files Size Format View

There are no files associated with this item.

The following license files are associated with this item:

Show simple item record

Αναφορά Δημιουργού-Μη Εμπορική Χρήση-Όχι Παράγωγα Έργα 3.0 Ηνωμένες Πολιτείες Except where otherwise noted, this item's license is described as Αναφορά Δημιουργού-Μη Εμπορική Χρήση-Όχι Παράγωγα Έργα 3.0 Ηνωμένες Πολιτείες